BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32047957)

  • 21. Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2.
    Meazza C; Cefalo G; Massimino M; Daolio P; Pastorino U; Scanagatta P; Morosi C; Podda M; Ferrari A; Terenziani M; Spreafico F; Casanova M; Parafioriti A; Collini P; Gandola L; Bastoni S; Biassoni V; Schiavello E; Chiaravalli S; Puma N; Bergamaschi L; Luksch R
    Med Oncol; 2017 Nov; 34(12):191. PubMed ID: 29094224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic osteosarcoma.
    Daw NC; Billups CA; Rodriguez-Galindo C; McCarville MB; Rao BN; Cain AM; Jenkins JJ; Neel MD; Meyer WH
    Cancer; 2006 Jan; 106(2):403-12. PubMed ID: 16353204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved Survival and Neurological Outcomes after Cardiopulmonary Resuscitation in Toll-like Receptor 4-mutant Mice.
    Xu L; Zhang Q; Zhang QS; Li Q; Han JY; Sun P
    Chin Med J (Engl); 2015 Oct; 128(19):2646-51. PubMed ID: 26415804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The absence of Toll-like receptor 4 signaling in C3H/HeJ mice predisposes them to overwhelming rickettsial infection and decreased protective Th1 responses.
    Jordan JM; Woods ME; Olano J; Walker DH
    Infect Immun; 2008 Aug; 76(8):3717-24. PubMed ID: 18490467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poor survival for osteosarcoma of the pelvis: a report from the Children's Oncology Group.
    Isakoff MS; Barkauskas DA; Ebb D; Morris C; Letson GD
    Clin Orthop Relat Res; 2012 Jul; 470(7):2007-13. PubMed ID: 22354612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteosarcoma and pulmonary metastases: 15-year experience from a single institution.
    Ellis PM; Tattersall MH; McCaughan B; Stalley P
    Aust N Z J Surg; 1997 Sep; 67(9):625-9. PubMed ID: 9322700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [K. pneumoniea endotoxin induced mice beta-defensin-4 mRNA expression and its signaling transduction].
    Cai S; Du J; Chen X; Huang N; Wang L; Ma X; Kiyoyuki K; Fumihiko N; Wang B; Takaiki H
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):157-62. PubMed ID: 12600073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4.
    Han S; Wang C; Qin X; Xia J; Wu A
    J Exp Clin Cancer Res; 2017 Jun; 36(1):83. PubMed ID: 28641579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
    Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
    Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrinsic and extrinsic manipulation of B7/CTLA-4 interaction for induction of anti-tumor immunity against osteosarcoma cells.
    Nagamori M; Kawaguchi S; Murakami M; Wada T; Nagoya S; Yamashita T; Inobe M; Uede T
    Anticancer Res; 2002; 22(6A):3223-7. PubMed ID: 12530068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective Analysis of Adoptive TIL Therapy plus Anti-PD1 Therapy in Patients with Chemotherapy-Resistant Metastatic Osteosarcoma.
    Zhou X; Wu J; Duan C; Liu Y
    J Immunol Res; 2020; 2020():7890985. PubMed ID: 33062726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut flora enhance bacterial clearance in lung through toll-like receptors 4.
    Tsay TB; Yang MC; Chen PH; Hsu CM; Chen LW
    J Biomed Sci; 2011 Sep; 18(1):68. PubMed ID: 21906393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of Toll-like receptor 4 on β2-glycoprotein I-induced B cell activation in mouse model.
    Cheng S; He C; Zhou H; Kong X; Xie H; Xia L; Yan J
    Mol Immunol; 2016 Mar; 71():78-86. PubMed ID: 26872007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
    Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
    Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salmonella administration induces a reduction of wheel-running activity via a TLR5-, but not a TLR4, dependent pathway in mice.
    Matsumoto T; Shiva D; Kawanishi N; Kato Y; Woods JA; Yano H
    Exerc Immunol Rev; 2008; 14():38-50. PubMed ID: 19203083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma.
    Baumhoer D; Smida J; Zillmer S; Rosemann M; Atkinson MJ; Nelson PJ; Jundt G; von Luettichau I; Nathrath M
    Mod Pathol; 2012 Apr; 25(4):522-8. PubMed ID: 22173290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of Toll-like receptor 4 decreases lipopolysaccharide-induced bone resorption in C3H/HeJ mice in vivo.
    Nakamura H; Fukusaki Y; Yoshimura A; Shiraishi C; Kishimoto M; Kaneko T; Hara Y
    Oral Microbiol Immunol; 2008 Jun; 23(3):190-5. PubMed ID: 18402604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma.
    Deng C; Xu Y; Fu J; Zhu X; Chen H; Xu H; Wang G; Song Y; Song G; Lu J; Liu R; Tang Q; Huang W; Wang J
    Cancer Sci; 2020 Jun; 111(6):1899-1909. PubMed ID: 32232912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience.
    Berlanga P; Cañete A; Díaz R; Salom M; Baixauli F; Gómez J; Llavador M; Castel V
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):e272-7. PubMed ID: 25374283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.